Quote:
Originally Posted by Injecto  What is Apidra? What does it do? |
Apidra is the latest rapid-acting insulin analog to be approved for blood sugar control in T1 and T2 individuals. I believe it came out in 2004? but I could be wrong about that. It's produced by Sanofi-Aventis, the same giant that produces Lantus, a long-acting insulin. Obviously they wanted to get into the rapid-acting insulin market too.
The first I'd ever heard of Apidra was here on this forum, sometime last year. It was only a few months ago that my doc even mentioned it to me. Like I mentioned above, it does the same thing as Humalog and Novolog; there are just slight structural differences between the three of them that may produce different action profiles among all of us. The anecdotal evidence I hear, based on stories I've heard from other diabetics, including my endo, is that Apidra tends to work a bit faster and is gone from your system/finished working faster than the other 2 analogs, Nov and Hum. But we're all different. I do love its speed and the way it works in my body and its ability to keep my post meal spikes down - that was nearly impossible for me before and those spikes always made me feel so bad.
